CancerDR: Cancer Drug Resistance Database

       General       Information        Submission        Acknowledgement      Guide      Links        Team        Contact

Browsing of Anticancer Drugs



This module allows users to browse anticancer drugs in CancerDR. This page summarizes the drugs with different descriptors like pI, Volume, Hydrogen Bond Acceptor, Hydrogen Bond Donor, Structure link, molecular targets. For more information, please click Help



Drug Name Pubchem ID Clinical Status Molecular Targets Number of Targets Target Class Chemical Formula Molecular Weight Polarizability pI Volume HBA HBD Cells Tried Structure
A44365410172943Experimental AKT1, AKT2, AKT33Ser Thr KinaseC24H23N5O397.472344.6211.61356.8143358
A7700419549184Experimental SRC1Tyrosine kinaseC34H39N9O3621.73268.869.67559.3482560
ABT26324978538Phase IBCL2, BCLXL, BCLW3ApoptosisC47H55ClF3N5O6S3974.613101.396.88837.13102574
ABT88811960529Phase IPARP1, PARP22DNA repairC13H16N4O244.292326.579.72220.6233503
AEW54111476171ExperimentalIGF1R1ApoptosisC27H29N5O439.552150.69405.0151479
AG0146999931953Phase I, Phase IIPARP1, PARP22DNA repairC19H21FN3O5P421.359337.1411.3923557
AICAR65110 Phase IIPRKAA1, 1MetabolismC9H15N4O8P338.211228.952.99256.5296562
AKTinhibitorVIII16218954Phase IIAKT1, AKT2, AKT33Ser Thr KinaseC36H32F3N7O4683.67961.829.7652667
AMG70611667893Phase I, Phase IIVEGFR1, VEGFR2, RET, KIT, PDGFRA, PDGFRB6Receptor Tyrosine kinaseC22H23N5O373.450939.389.05341.7453560
AP2453424826799Phase IABL11Tyrosine kinaseC29H27F3N6O532.559556.189.67461.3251667
AS60124511422035Experimental JNK1, JNK2, JNK33Ser Thr KinaseC20H16N6S372.44639.388.38317.9662661
ATRA444795ApprovedRXRB, RXRG, RAR13Transcription, C20H28O2300.435136.62312.3621573
AUY92210096043Phase IIHSP90AA1, HSP90AB1, HSP90AB4P, HSP90B1, 5ApoptosisC26H31N3O5465.541450.837.32425.0373661
Axitinib6450551ApprovedPDGFRA, PDGFRB, KIT, VEGFR24Receptor Tyrosine kinaseC22H18N4OS386.4742.679334.2732576
AZ62811676786Experimental BRAF1Receptor Tyrosine kinaseC27H25N5O2451.519748.238.81410.7552354
AZD053010302451Phase IISRC, ABL12Tyrosine kinaseC27H32ClN5O5542.02657.259.94472.15101865
AZD228123725625Phase I PARP1, PARP22DNA repairC24H23FN4O3434.462843.545.96375.6541557
AZD624410127622Phase IIMAP2K1, MAP2K22Ser Thr KinaseC17H15BrClFN4O3457.68140.737.79323.52531033
AZD648244137675Phase IPI3KCB, PI3KC2B2ApoptosisC22H24N4O4408.450442.773.32364.4372667
AZD77621152667Phase ICHK1, CHK22Ser Thr KinaseC18H21FN4O2S376.44839.4512.28324.2944574
AZD805525262965Phase IMTOR1Ser Thr KinaseC25H31N5O4465.544751.448.89425.9791553
BAY61360616760671Experimental SYK1Tyrosine kinaseC20H23ClN6O5462.88740.669.0572661
Bexarotene82146ApprovedRXRA, RXRB, RXRG3TranscriptionC24H28O2348.477940.89349.4921538
BI253611364421Phase IIPLK1, PLK2, PLK33Ser Thr Kinase, MitosisC28H39N7O3521.654459.6710491.8482359
BIBW299244569596Phase IIIEGFR, ERBB22Receptor Tyrosine kinaseC25H26ClFN4O3484.9550.810.7417.762576
Bicalutamide2375ApprovedAR1MetabolismC18H14F4N2O4S430.37336.683.95332.4552661
BID187025023738Experimental RSK1, RSK2, RSK3, PLK1, AURKB5Ser Thr KinaseC19H23F2N5O2391.41539.816.59342.8262573
BIRB0796156422Experimental MAPK11, MAPK12, MAPK13, MAPK14, JNK25Ser Thr KinaseC31H37N5O3527.657258.539.11495.6352573
Bleomycin5460769ApprovedDNAdamage1DNA repairC55H84N17O21S31415.552140.8811.411211.932820661
BMS50974420635522Experimental ITK1Tyrosine kinaseC31H39N5O4S2609.80267.999.83555.762359
BMS53692410390396Experimental IGF1R1ApoptosisC25H26ClN5O3479.95951.48.35409.9584359
BMS70816346883536Phase II Gamma-secretase1Cell cycleC20H17ClF4N4O4S520.88544.025.28394.3251358
BMS75480724785538Phase I IGF1R1Ser Thr KinaseC23H24FN9O461.494848.118.81389.573482
Bortezomib387447ApprovedProteasome1Cell cycleC19H25BN4O4384.23740.256.13364.2564661
Bosutinib5328940Phase IABL1, SRC, TEC3Tyrosine kinaseC26H29Cl2N5O3530.44656.211.96460.5181354
Bryostatin5280757Phase IIPRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH10Angiogenesis, ApoptosisC47H68O17905.032696.013.96847.67124574
BX79510077147ExperimentalTBK1, PDK1, IKBKE, AURKB, AURKC5Ser Thr KinaseC23H26IN7O2S591.468568.96434.8764661
Camptothecin104842Approved TOP1, 1DNA repairC22H20N2O5392.404641.436.79336.2352667
CCT007093NAExperimentalPPM1D1Stress pathwayC15H12OS2272.38529.12229.1310468
CCT018159NAExperimentalHSP901Stress pathwayC17H15ClN2O3330.76633.725.27271.1853358
CEP701126565Phase IIFLT3, JAK2, NTRK1, RET4Tyrosine kinaseC26H21N3O4439.462646.95.38364.7643661
CGP08299624825971Experimental CDK41Ser Thr KinaseC27H32N6O456.582653.079.5426.4164482
CGP60474644215Experimental CDK1, CDK2, CDK5, CDK7, CDK95Cell cycleC18H18ClN5O355.82138.539.22307.1763470
CHIR990219956119Experimental GSK3B1Tyrosine kinaseC22H18Cl2N8465.33848.149.46378.7173576
CI10406918454Phase IIMAP2K1, MAP2K22Ser Thr KinaseC17H14ClF2IN2O2478.6639.333.89308.3232358
Cisplatin84691ApprovedDNAdamage1ReplicationCl2H6N2Pt300.0511.9911573
CMKNAExperimental RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA4, RPS66Ser Thr KinaseC17H17ClN4O2344.79535.7611.08292.0852358
Cyclopamine442972Experimental SMO1AngiogenesisC27H41NO2411.619950.64418.2232458
Cytarabine6253ApprovedDNAsynthesis1MetabolismC9H13N3O5243.216622.216.64201.2674576
Dasatinib3062316ApprovedABL1, ABL2, PDGFRB, FYN, 4Receptor Tyrosine kinaseC22H26ClN7O2S488.00651.587.83416.4783354